17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells

<p>Abstract</p> <p>Background</p> <p>17-Allylamino-17-demethoxygeldanamycin (17-AAG), a benzoquinone ansamycin antibiotic, specifically targets heat shock protein 90 (Hsp90) and interferes with its function as a molecular chaperone that maintains the structural and func...

Full description

Bibliographic Details
Main Authors: Karkoulis Panagiotis K, Stravopodis Dimitrios J, Margaritis Lukas H, Voutsinas Gerassimos E
Format: Article
Language:English
Published: BMC 2010-09-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/481
id doaj-f5939282cc354e38926b995407912347
record_format Article
spelling doaj-f5939282cc354e38926b9954079123472020-11-25T00:26:18ZengBMCBMC Cancer1471-24072010-09-0110148110.1186/1471-2407-10-48117-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cellsKarkoulis Panagiotis KStravopodis Dimitrios JMargaritis Lukas HVoutsinas Gerassimos E<p>Abstract</p> <p>Background</p> <p>17-Allylamino-17-demethoxygeldanamycin (17-AAG), a benzoquinone ansamycin antibiotic, specifically targets heat shock protein 90 (Hsp90) and interferes with its function as a molecular chaperone that maintains the structural and functional integrity of various protein clients involved in cellular signaling. In this study, we have investigated the effect of 17-AAG on the regulation of Hsp90-dependent signaling pathways directly implicated in cell cycle progression, survival and motility of human urinary bladder cancer cell lines.</p> <p>Methods</p> <p>We have used MTT-based assays, FACS analysis, Western blotting, semi-quantitative RT-PCR, immunocytochemistry and scratch-wound assay in RT4, RT112 and T24 human urinary bladder cancer cell lines.</p> <p>Results</p> <p>We have demonstrated that, upon 17-AAG treatment, bladder cancer cells are arrested in the G1 phase of the cell cycle and eventually undergo apoptotic cell death in a dose-dependent manner. Furthermore, 17-AAG administration was shown to induce a pronounced downregulation of multiple Hsp90 protein clients and other downstream effectors, such as IGF-IR, Akt, IKK-α, IKK-β, FOXO1, ERK1/2 and c-Met, resulting in sequestration-mediated inactivation of NF-κB, reduced cell proliferation and decline of cell motility.</p> <p>Conclusions</p> <p>In total, we have clearly evinced a dose-dependent and cell type-specific effect of 17-AAG on cell cycle progression, survival and motility of human bladder cancer cells, due to downregulation of multiple Hsp90 clients and subsequent disruption of signaling integrity.</p> http://www.biomedcentral.com/1471-2407/10/481
collection DOAJ
language English
format Article
sources DOAJ
author Karkoulis Panagiotis K
Stravopodis Dimitrios J
Margaritis Lukas H
Voutsinas Gerassimos E
spellingShingle Karkoulis Panagiotis K
Stravopodis Dimitrios J
Margaritis Lukas H
Voutsinas Gerassimos E
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
BMC Cancer
author_facet Karkoulis Panagiotis K
Stravopodis Dimitrios J
Margaritis Lukas H
Voutsinas Gerassimos E
author_sort Karkoulis Panagiotis K
title 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
title_short 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
title_full 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
title_fullStr 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
title_full_unstemmed 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
title_sort 17-allylamino-17-demethoxygeldanamycin induces downregulation of critical hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2010-09-01
description <p>Abstract</p> <p>Background</p> <p>17-Allylamino-17-demethoxygeldanamycin (17-AAG), a benzoquinone ansamycin antibiotic, specifically targets heat shock protein 90 (Hsp90) and interferes with its function as a molecular chaperone that maintains the structural and functional integrity of various protein clients involved in cellular signaling. In this study, we have investigated the effect of 17-AAG on the regulation of Hsp90-dependent signaling pathways directly implicated in cell cycle progression, survival and motility of human urinary bladder cancer cell lines.</p> <p>Methods</p> <p>We have used MTT-based assays, FACS analysis, Western blotting, semi-quantitative RT-PCR, immunocytochemistry and scratch-wound assay in RT4, RT112 and T24 human urinary bladder cancer cell lines.</p> <p>Results</p> <p>We have demonstrated that, upon 17-AAG treatment, bladder cancer cells are arrested in the G1 phase of the cell cycle and eventually undergo apoptotic cell death in a dose-dependent manner. Furthermore, 17-AAG administration was shown to induce a pronounced downregulation of multiple Hsp90 protein clients and other downstream effectors, such as IGF-IR, Akt, IKK-α, IKK-β, FOXO1, ERK1/2 and c-Met, resulting in sequestration-mediated inactivation of NF-κB, reduced cell proliferation and decline of cell motility.</p> <p>Conclusions</p> <p>In total, we have clearly evinced a dose-dependent and cell type-specific effect of 17-AAG on cell cycle progression, survival and motility of human bladder cancer cells, due to downregulation of multiple Hsp90 clients and subsequent disruption of signaling integrity.</p>
url http://www.biomedcentral.com/1471-2407/10/481
work_keys_str_mv AT karkoulispanagiotisk 17allylamino17demethoxygeldanamycininducesdownregulationofcriticalhsp90proteinclientsandresultsincellcyclearrestandapoptosisofhumanurinarybladdercancercells
AT stravopodisdimitriosj 17allylamino17demethoxygeldanamycininducesdownregulationofcriticalhsp90proteinclientsandresultsincellcyclearrestandapoptosisofhumanurinarybladdercancercells
AT margaritislukash 17allylamino17demethoxygeldanamycininducesdownregulationofcriticalhsp90proteinclientsandresultsincellcyclearrestandapoptosisofhumanurinarybladdercancercells
AT voutsinasgerassimose 17allylamino17demethoxygeldanamycininducesdownregulationofcriticalhsp90proteinclientsandresultsincellcyclearrestandapoptosisofhumanurinarybladdercancercells
_version_ 1725344837386895360